US 7488758
Levalbuterol hydrochloride polymorph B
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7488758 (Levalbuterol hydrochloride polymorph B) held by Teva Pharmaceutical Fine Chemicals S.R.L. expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Pharmaceutical Fine Chemicals S.R.L.
- Grant date
- Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P43/00